Sort
141,003 grants matching “cytokine”
Immunity to Pneumonic Tularemia
$647,802Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Cannabis, inflammation, and the brain in persons with HIV
$647,799Jennifer E Iudicello · University Of California, San Diego · R01 · FY2020 · DA
Identifying, Characterizing and Inducing Effective Anti-HIV T Cell Responses
$647,720Helen Horton · Seattle Biomedical Research Institute · R01 · FY2010 · AI
Prevalence and Clinical Correlates of Thirdhand Smoke Exposure in a Pediatric Patient Population
$647,716E. Melinda Melinda Mahabee-Gittens · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · ES
Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease
$647,711Lisa A Maier · National Jewish Health · R01 · FY2023 · ES
Ex vivo perfusion in a lung box for rehabilitation of donor lungs
$647,681Irving L Kron · University Of Virginia · R01 · FY2015 · HL
ALL immunobiology and the bone marrow niche
$647,674Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
BRAIN OXIDATION IN THE PATHOGENESIS OF AD
$647,664University Of Kentucky · P01 · FY2000 · AG
Improved Chimeric Antigen Receptor Therapies B-cell Malignancies
$647,651James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
TNF-alpha-"armed" TCR vectors to enhance adoptive cell therapy for solid tumors
$647,632Theodore Scott Nowicki · University Of California Los Angeles · R37 · FY2025 · CA
Mechanisms of Neuropeptides Action in Diabetes
$647,619Aristidis Veves · Beth Israel Deaconess Medical Center · R01 · FY2011 · DK
Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations
$647,617Lisa Forbes · Baylor College Of Medicine · UG3 · FY2021 · TR
Evaluating SARS-CoV-2 spike antigen-induced coagulopathy and neuroinflammation as mechanistic drivers of neurologic PASC
$647,609Michael Joseph Peluso · University Of California, San Francisco · R01 · FY2025 · NS
Drug delivery by carrier erythrocytes
$647,597Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2015 · HL
Mapping novel subdominant B*5701 epitopes in conserved regions of the HIV proteom
$647,593June Kan-Mitchell · University Of Texas El Paso · R01 · FY2011 · AI
Maternal mediators of fetal growth restriction linked to prenatal alcohol exposure
$647,586Christina Chambers · University Of California, San Diego · R01 · FY2023 · AA
New strategies for treating septic vasculopathy, inflammation and thrombosis
$647,554Xiaoping Du · University Of Illinois At Chicago · R01 · FY2014 · HL
New strategies for treating septic vasculopathy, inflammation and thrombosis
$647,554Xiaoping Du · University Of Illinois At Chicago · R01 · FY2016 · HL
Interactions of smoking, PD-1 and IL-10 in HIV-associated lung disease
$647,522Andrew P Fontenot · University Of Colorado Denver · U01 · FY2013 · HL
Antiviral response coupled with transposon derepression in Alzheimer's disease and aging
$647,485Wei Cao · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · AG
Methamphetamine, Stress and SIV: Effects at Blood-Brain Barrier and Lymph Nodes
$647,434John P Capitanio · University Of California At Davis · R01 · FY2009 · DA
Characterize the Landscape and Origin of Hybrid Peptides in Beta Cells
$647,409Thomas Delong · University Of Colorado Denver · R01 · FY2025 · DK
Pharmacologic and pharmacogenetic associations with recurrent venous thrombosis
$647,379Nicholas L Smith · University Of Washington · R01 · FY2010 · HL
Engineering of biomaterials with controlled biomolecule delivery for cardiovascular applications
$647,359Monica T Hinds · Oregon Health & Science University · R01 · FY2024 · HL
Directing Antibody Effector Activity via Controlled IgG Subclass Switching
$647,344Margaret E Ackerman · Dartmouth College · R01 · FY2020 · AI